Covid-19 and patient behaviour: what has changed?
Panellists:
- Harry Yeates, Strategy Director, Langland
- David Griffiths, GP, Chief Medical Officer at Teladoc Health UK
- Penny Clarke, Lymphoma Patient Advocate
- Siân Dodwell, Chief Strategy Officer, Langland
After a forest fire, the natural world recovers according to predictable patterns, in a process known as ‘ecological succession’. The modern world has never seen a global conflagration quite like Covid-19, so what will those equivalent patterns look like for healthcare? Join Langland and a panel of health experts as they ask how the pandemic will change the way individuals manage their own health, how healthcare companies interact with patients, and the status of health literacy on the global health agenda.
No items found.
Thought Leadership
Sep 23, 2024
The silent risk of hypertrophic cardiomyopathy
Ahead of World Heart Day on 29 September, we are shining a light on hypertrophic cardiomyopathy (HCM) and the work by Max’s Foundation, a volunteer-led charity founded by Senior Medical Writer I, Molly Schiller and her family, to support research and education on the condition.
Thought Leadership
Mar 28, 2024
Our ability to combat the spread of fake news in the pharmaceutical industry will shape our future
Account Director in Public Relations at Langland, Alexandra Walton, reflects on a thought-provoking panel at the PRWeek UK PharmaComms Conference, ‘Disinformation and misinformation – how can pharma communicators fight it?’
